Skip to main content

Table 1 Clinico-pathological characteristics and association to PD-L1 (cut-off 5%)

From: Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

 

Number

PD-L1

 

(N = 572) (%)

Low (%)

High (%)

p-value

Age (years at diagnosis)

 Median

72

   

 Range

29–95

   

  ≥ 73

267 (47)

253 (47)

14 (40)

0.414

  < 73

305 (53)

284 (53)

21 (60)

 

Gender

 Male

283 (49)

272 (51)

11 (31)

0.028

 Female

289 (51)

265 (49)

24 (69)

 

T-stage

 pT3

500 (87)

472 (88)

28 (80)

0.172

 pT4

72 (13)

65 (12)

7 (20)

 

Histology (WHO)

 Adenocarcinoma NOS

515 (90)

481 (90)

34 (97)

0.348

 Mucinous adenocarcinoma

55 (10)

54 (10)

1 (3)

 

 Signet-ring cell carcinoma

2 (0)

2 (1)

0 (0)

 

Malignancy grade

 Medium + low

450 (79)

436 (81)

14 (40)

< 0.001

 Higha

122 (21)

101 (19)

21 (60)

 

Localisation

 Right

273 (48)

242 (45)

31 (89)

< 0.001

 Left

299 (52)

295 (55)

4 (11)

 

Tumour perforation

 Yes

530 (93)

499 (97)

31 (94)

0.313

 No

17 (3)

15 (3)

2 (6)

 

 Unknown

25 (4)

   

Lymph nodes

 Median

10

   

 Range

0–41

   

  < 12 nodes

351 (61)

329 (61)

22 (63)

0.851

  ≥ 12 nodes

221 (39)

208 (39)

13 (37)

 

Perineural invasion

 Yes

26 (5)

25 (7)

1 (4)

0.635

 No

359 (63)

337 (93)

22 (96)

 

 Not assessed

187 (32)

   

Vascular invasion

 Yes

43 (7)

38 (9)

5 (22)

0.054

 No

386 (68)

368 (91)

18 (78)

 

 Not assessed

143 (25)

   

Mismatch repair status

 MSS

400 (70)

396 (74)

4 (11)

< 0.001

 MSI

172 (30)

141 (26)

31 (89)

 
  1. Abbreviations: MSI microsatellite instability, MSS microsatellite stable, NOS not otherwise specified
  2. aIncluding mucinous adenocarcinomas and signet-ring cell carcinomas
  3. P-values are obtained using chi2-test. Statistically significant p-values are highlighted in bold